Shorter telomere length in peripheral blood cells associated with migraine in women

Headache

Volumn 50, Issue 6, 2010, Pages 965-972

  Ren, Hua ^a   Collins, Veronica ^a   Fernandez, Francesca ^b   Quinlan, Sharon ^b   Griffiths, Lyn ^b   Choo, K H Andy ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

Aging; Migraine; Telomere; Telomere length

Indexed keywords

ADULT; AGED; AGING; ARTICLE; BODY MASS; CAUCASIAN; CELL FUNCTION; CHROMOSOME SIZE; CHRONIC DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MIGRAINE; ONSET AGE; PATHOPHYSIOLOGY; PERIPHERAL BLOOD STEM CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; STRESS; TELOMERE; ADOLESCENT; GENETICS; MIDDLE AGED; MONONUCLEAR CELL;

ADOLESCENT; ADULT; AGED; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; MIGRAINE DISORDERS; POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; TELOMERE;

EID: 77953214618     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2010.01693.x     Document Type: Article

References (40)

1. Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence. A review of population-based studies. Neurology. 1994 44 : S17 S23.
2. Lewis DW, Yonker M, Winner P, Sowell M. The treatment of pediatric migraine. Pediatr Ann. 2005 34 : 448 460.
3. Hawkins K, Wang S, Rupnow MF. Indirect cost burden of migraine in the United States. J Occup Environ Med. 2007 49 : 368 374.
4. Olesen J, Lekander I, Andlin-Sobocki P, Jonsson B. Funding of headache research in Europe. Cephalalgia. 2007 27 : 995 999.
5. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med. 2002 8 : 136 142.
6. Leistad RB, Stovner LJ, White LR, Nilsen KB, Westgaard RH, Sand T. Noradrenaline and cortisol changes in response to low-grade cognitive stress differ in migraine and tension-type headache. J Headache Pain. 2007 8 : 157 166.
7. Yilmaz G, Surer H, Inan LE, Coskun O, Yucel D. Increased nitrosative and oxidative stress in platelets of migraine patients. Tohoku J Exp Med. 2007 211 : 23 30.
8. Fernandez F, Colson N, Griffiths L. Pharmacogenetics of migraine: Genetic variants and their potential role in migraine therapy. Pharmacogenomics. 2007 8 : 609 622.
9. Chan SR, Blackburn EH. Telomeres and telomerase. Philos Trans R Soc Lond B Biol Sci. 2004 359 : 109 121.
10. Collerton J, Martin-Ruiz C, Kenny A, et al. Telomere length is associated with left ventricular function in the oldest old: The Newcastle 85+ study. Eur Heart J. 2007 28 : 172 176.
11. Epel ES, Blackburn EH, Lin J, et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A. 2004 101 : 17312 17315.
12. Simon NM, Smoller JW, McNamara KL, et al. Telomere shortening and mood disorders: Preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry. 2006 60 : 432 435.
13. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci. 2002 27 : 339 344.
14. Olesen J, Bousser M-G, Diener H-C, et al. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004 24 (Suppl. 1 9 160.
15. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002 30 : e47.
16. Kapoor V, Telford WG. Telomere length measurement by fluorescence in situ hybridization and flow cytometry. Methods Mol Biol. 2004 263 : 385 398.
17. Valdes AM, Andrew T, Gardner JP, et al. Obesity, cigarette smoking, and telomere length in women. Lancet. 2005 366 : 662 664.
18. Blackburn EH. Telomere states and cell fates. Nature. 2000 408 : 53 56.
19. Serra V, von Zglinicki T, Lorenz M, Saretzki G. Extracellular superoxide dismutase is a major antioxidant in human fibroblasts and slows telomere shortening. J Biol Chem. 2003 278 : 6824 6830.
20. Meyer TD, Rietzschel ER, Buyzere ML, Criekinge WV, Bekaert S. Studying telomeres in a longitudinal population based study. Front Biosci. 2008 13 : 2960 2970.
21. Aviv A, Valdes A, Gardner JP, Swaminathan R, Kimura M, Spector TD. Menopause modifies the association of leukocyte telomere length with insulin resistance and inflammation. J Clin Endocrinol Metab. 2006 91 : 635 640.
22. Demissie S, Levy D, Benjamin EJ, et al. Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell. 2006 5 : 325 330.
23. Panossian LA, Porter VR, Valenzuela HF, et al. Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging. 2003 24 : 77 84.
24. Zhai G, Aviv A, Hunter DJ, et al. Reduction of leucocyte telomere length in radiographic hand osteoarthritis: A population-based study. Ann Rheum Dis. 2006 65 : 1444 1448.
25. Metcalfe JA, Parkhill J, Campbell L, et al. Accelerated telomere shortening in ataxia telangiectasia. Nat Genet. 1996 13 : 350 353.
26. Shen J, Terry MB, Gurvich I, Liao Y, Senie RT, Santella RM. Short telomere length and breast cancer risk: A study in sister sets. Cancer Res. 2007 67 : 5538 5544.
27. Trkova M, Prochazkova K, Krutilkova V, Sumerauer D, Sedlacek Z. Telomere length in peripheral blood cells of germline TP53 mutation carriers is shorter than that of normal individuals of corresponding age. Cancer. 2007 110 : 694 702.
28. Benetos A, Gardner JP, Zureik M, et al. Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects. Hypertension. 2004 43 : 182 185.
29. Brouilette SW, Moore JS, McMahon AD, et al. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: A nested case-control study. Lancet. 2007 369 : 107 114.
30. Uziel O, Singer JA, Danicek V, et al. Telomere dynamics in arteries and mononuclear cells of diabetic patients: Effect of diabetes and of glycemic control. Exp Gerontol. 2007 42 : 971 978.
31. Sampson MJ, Winterbone MS, Hughes JC, Dozio N, Hughes DA. Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes. Diabetes Care. 2006 29 : 283 289.
32. Farzaneh-Far R, Lin J, Epel ES, Harris WS, Blackburn EH, Whooley MA. Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. JAMA. 2010 303 : 250 257.
33. Albert CM, Campos H, Stampfer MJ, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002 346 : 1113 1118.
34. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and reinfarction trial (DART). Lancet. 1989 2 : 757 761.
35. Lee JH, O'Keefe JH, Lavie CJ, Marchioli R, Harris WS. Omega-3 fatty acids for cardioprotection. Mayo Clin Proc. 2008 83 : 324 332.
36. Marchioli R, Barzi F, Bomba E, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation. 2002 105 : 1897 1903.
37. Tamayo M, Mosquera A, Rego JI, Fernandez-Sueiro JL, Blanco FJ, Fernandez JL. Differing patterns of peripheral blood leukocyte telomere length in rheumatologic diseases. Mutat Res. 2010 683 : 68 73.
38. Mathur S. Epidemic of coronary heart disease and its treatment in Australia: CARDIOVASCULAR DISEASE SERIES, 2002.
39. CATI Technical Reference Group, National Public Health Partnership. Population Health Monitoring and Surveillance: Question Development Background Paper Cardiovascular Disease in Australia, 2003.
40. Commonwealth Department of Health and Age Care, Australian Institute of Health and Welfare. National Health Priority Areas Report Mental health A REPORT FOCUSING ON DEPRESSION, 1998.